pipette
ENEnglish

Recoding by N1-methylpseudouridine guides rational mRNA vaccine design

Panagiotis Poulis, Giovanni Robecchi, Arina O. Kurochkina, Michèle Felletti, Marina V. Rodnina

Revista con revisión por paresUso en el mundo real

En palabras de los autores

Abstract N 1 -methylpseudouridine (m 1 Ψ) is a key modification used in SARS-CoV-2 mRNA vaccines that reduces immunogenicity and increases mRNA stability. Recent studies suggested that m 1 Ψ can promote ribosomal frameshifting, a translational error generating aberrant peptides that elicit immune responses, raising concerns about unintended antigenicity. Here, we systematically examined the efficiency of frameshifting induced by m 1 Ψ and the underlying mechanism, aiming to inform future mRNA vaccine design. Using mRNA-based dual-fluorescence reporters in cells, fully in vitro reconstituted translation system, and single-molecule FRET microscopy, we show that m 1 Ψ increases +1 frameshifting on UUUC motifs in therapeutic mRNAs. Frameshifting occurs when the peptidyl-tRNA pauses in the ribosomal P site, where m 1 Ψ both weakens codon-anticodon interactions and promotes a frameshifting-prone tRNA conformation. Replacing slippery UUUC motifs with UUCC or UUUU eliminates this effect. Our results reveal how a clinically relevant mRNA modification promotes recoding and show that codon optimization mitigates this risk in therapeutic mRNA design.

Resultado principalEl resumen no menciona limitaciones.

Apareció: miércoles, 30 de septiembre. Nature Communications. Revista con revisión por pares.

DOI: 10.1038/s41467-026-77796-3